According to a new report from Intel Market Research, the global Early Phase Clinical Trial Outsourcing Market was valued at USD 5.8 billion in 2025 and is projected to reach USD 11.3 billion by 2034, growing at a robust CAGR of 7.1 % during the forecast period (2025–2034). This expansion is fueled by rising R&D budgets, heightened regulatory expectations, and the increasing need...